NCT05937620View on ClinicalTrials.gov

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Ovarian Epithelial Cancer
Interventions
DIAGNOSTIC_TEST

99mTC nanocolloid albumin injection

All patients will receive an injection of both tracers in order to detect the sentinel lymph node

DIAGNOSTIC_TEST

ICG injection

All patients will receive an injection of both tracers in order to detect the sentinel lymph node

All Listed Sponsors
lead

Fundacion Clinic per a la Recerca Biomédica

OTHER

NCT05937620 - Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer | Biotech Hunter | Biotech Hunter